Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 1, no: 9 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: A4HB97
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 232 | 236 | PF00656 | 0.537 |
CLV_NRD_NRD_1 | 113 | 115 | PF00675 | 0.598 |
CLV_NRD_NRD_1 | 120 | 122 | PF00675 | 0.589 |
CLV_NRD_NRD_1 | 28 | 30 | PF00675 | 0.566 |
CLV_NRD_NRD_1 | 3 | 5 | PF00675 | 0.579 |
CLV_NRD_NRD_1 | 40 | 42 | PF00675 | 0.613 |
CLV_PCSK_KEX2_1 | 113 | 115 | PF00082 | 0.600 |
CLV_PCSK_KEX2_1 | 120 | 122 | PF00082 | 0.589 |
CLV_PCSK_KEX2_1 | 28 | 30 | PF00082 | 0.553 |
CLV_PCSK_KEX2_1 | 3 | 5 | PF00082 | 0.588 |
CLV_PCSK_KEX2_1 | 40 | 42 | PF00082 | 0.613 |
CLV_PCSK_SKI1_1 | 141 | 145 | PF00082 | 0.504 |
CLV_PCSK_SKI1_1 | 222 | 226 | PF00082 | 0.515 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.635 |
DEG_SPOP_SBC_1 | 226 | 230 | PF00917 | 0.549 |
DOC_CYCLIN_yCln2_LP_2 | 186 | 192 | PF00134 | 0.510 |
DOC_MAPK_gen_1 | 120 | 127 | PF00069 | 0.557 |
DOC_MAPK_gen_1 | 3 | 10 | PF00069 | 0.446 |
DOC_MAPK_MEF2A_6 | 120 | 129 | PF00069 | 0.443 |
DOC_PP2B_LxvP_1 | 50 | 53 | PF13499 | 0.485 |
DOC_PP2B_LxvP_1 | 56 | 59 | PF13499 | 0.403 |
DOC_USP7_MATH_1 | 154 | 158 | PF00917 | 0.648 |
DOC_USP7_MATH_1 | 226 | 230 | PF00917 | 0.640 |
DOC_USP7_MATH_1 | 46 | 50 | PF00917 | 0.653 |
LIG_14-3-3_CanoR_1 | 12 | 16 | PF00244 | 0.609 |
LIG_14-3-3_CanoR_1 | 120 | 124 | PF00244 | 0.562 |
LIG_14-3-3_CanoR_1 | 159 | 165 | PF00244 | 0.691 |
LIG_14-3-3_CanoR_1 | 185 | 189 | PF00244 | 0.771 |
LIG_14-3-3_CanoR_1 | 40 | 44 | PF00244 | 0.649 |
LIG_CaM_NSCaTE_8 | 7 | 14 | PF13499 | 0.651 |
LIG_CtBP_PxDLS_1 | 126 | 130 | PF00389 | 0.438 |
LIG_eIF4E_1 | 88 | 94 | PF01652 | 0.519 |
LIG_FHA_1 | 142 | 148 | PF00498 | 0.551 |
LIG_FHA_1 | 161 | 167 | PF00498 | 0.463 |
LIG_FHA_1 | 201 | 207 | PF00498 | 0.564 |
LIG_FHA_1 | 65 | 71 | PF00498 | 0.344 |
LIG_FHA_2 | 230 | 236 | PF00498 | 0.663 |
LIG_FHA_2 | 40 | 46 | PF00498 | 0.648 |
LIG_LIR_Gen_1 | 258 | 267 | PF02991 | 0.555 |
LIG_LIR_Gen_1 | 6 | 15 | PF02991 | 0.626 |
LIG_LIR_Nem_3 | 191 | 197 | PF02991 | 0.666 |
LIG_LIR_Nem_3 | 258 | 263 | PF02991 | 0.552 |
LIG_LIR_Nem_3 | 6 | 10 | PF02991 | 0.627 |
LIG_PCNA_yPIPBox_3 | 210 | 218 | PF02747 | 0.291 |
LIG_Pex14_2 | 205 | 209 | PF04695 | 0.525 |
LIG_SH2_STAP1 | 220 | 224 | PF00017 | 0.438 |
LIG_SH2_STAT3 | 146 | 149 | PF00017 | 0.658 |
LIG_SH2_STAT5 | 146 | 149 | PF00017 | 0.639 |
LIG_SH2_STAT5 | 88 | 91 | PF00017 | 0.425 |
LIG_SH2_STAT5 | 98 | 101 | PF00017 | 0.362 |
LIG_SH3_3 | 120 | 126 | PF00018 | 0.439 |
LIG_SH3_3 | 31 | 37 | PF00018 | 0.491 |
LIG_SH3_3 | 75 | 81 | PF00018 | 0.476 |
LIG_Sin3_3 | 31 | 38 | PF02671 | 0.493 |
LIG_SUMO_SIM_anti_2 | 253 | 258 | PF11976 | 0.489 |
LIG_SUMO_SIM_anti_2 | 6 | 14 | PF11976 | 0.402 |
LIG_SUMO_SIM_par_1 | 125 | 130 | PF11976 | 0.433 |
LIG_TRAF2_1 | 115 | 118 | PF00917 | 0.349 |
LIG_UBA3_1 | 139 | 148 | PF00899 | 0.372 |
MOD_CK1_1 | 157 | 163 | PF00069 | 0.439 |
MOD_CK1_1 | 184 | 190 | PF00069 | 0.760 |
MOD_CK1_1 | 199 | 205 | PF00069 | 0.366 |
MOD_CK1_1 | 229 | 235 | PF00069 | 0.653 |
MOD_CK1_1 | 258 | 264 | PF00069 | 0.503 |
MOD_CK1_1 | 48 | 54 | PF00069 | 0.654 |
MOD_CK2_1 | 190 | 196 | PF00069 | 0.735 |
MOD_CK2_1 | 39 | 45 | PF00069 | 0.657 |
MOD_GlcNHglycan | 156 | 159 | PF01048 | 0.647 |
MOD_GlcNHglycan | 198 | 201 | PF01048 | 0.617 |
MOD_GlcNHglycan | 20 | 24 | PF01048 | 0.663 |
MOD_GlcNHglycan | 257 | 260 | PF01048 | 0.335 |
MOD_GSK3_1 | 129 | 136 | PF00069 | 0.427 |
MOD_GSK3_1 | 176 | 183 | PF00069 | 0.657 |
MOD_GSK3_1 | 196 | 203 | PF00069 | 0.335 |
MOD_GSK3_1 | 225 | 232 | PF00069 | 0.663 |
MOD_GSK3_1 | 255 | 262 | PF00069 | 0.488 |
MOD_GSK3_1 | 48 | 55 | PF00069 | 0.636 |
MOD_NEK2_1 | 10 | 15 | PF00069 | 0.560 |
MOD_NEK2_1 | 119 | 124 | PF00069 | 0.485 |
MOD_NEK2_1 | 127 | 132 | PF00069 | 0.404 |
MOD_NEK2_1 | 190 | 195 | PF00069 | 0.759 |
MOD_NEK2_1 | 225 | 230 | PF00069 | 0.557 |
MOD_NEK2_1 | 70 | 75 | PF00069 | 0.501 |
MOD_NEK2_1 | 89 | 94 | PF00069 | 0.225 |
MOD_NEK2_2 | 133 | 138 | PF00069 | 0.433 |
MOD_NEK2_2 | 220 | 225 | PF00069 | 0.461 |
MOD_PIKK_1 | 276 | 282 | PF00454 | 0.449 |
MOD_PIKK_1 | 64 | 70 | PF00454 | 0.515 |
MOD_PKA_2 | 11 | 17 | PF00069 | 0.480 |
MOD_PKA_2 | 119 | 125 | PF00069 | 0.530 |
MOD_PKA_2 | 184 | 190 | PF00069 | 0.682 |
MOD_PKA_2 | 39 | 45 | PF00069 | 0.647 |
MOD_Plk_1 | 127 | 133 | PF00069 | 0.436 |
MOD_Plk_1 | 141 | 147 | PF00069 | 0.483 |
MOD_Plk_1 | 190 | 196 | PF00069 | 0.742 |
MOD_Plk_1 | 200 | 206 | PF00069 | 0.374 |
MOD_Plk_1 | 220 | 226 | PF00069 | 0.240 |
MOD_Plk_1 | 240 | 246 | PF00069 | 0.536 |
MOD_Plk_4 | 213 | 219 | PF00069 | 0.410 |
MOD_Plk_4 | 259 | 265 | PF00069 | 0.494 |
MOD_Plk_4 | 52 | 58 | PF00069 | 0.518 |
MOD_Plk_4 | 89 | 95 | PF00069 | 0.423 |
TRG_DiLeu_BaEn_1 | 6 | 11 | PF01217 | 0.396 |
TRG_DiLeu_BaLyEn_6 | 135 | 140 | PF01217 | 0.445 |
TRG_ER_diArg_1 | 119 | 121 | PF00400 | 0.577 |
TRG_ER_diArg_1 | 39 | 41 | PF00400 | 0.648 |
TRG_Pf-PMV_PEXEL_1 | 138 | 142 | PF00026 | 0.456 |
TRG_Pf-PMV_PEXEL_1 | 41 | 45 | PF00026 | 0.602 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I090 | Leptomonas seymouri | 48% | 100% |
A0A1X0PB36 | Trypanosomatidae | 29% | 100% |
A0A3Q8ILI1 | Leishmania donovani | 78% | 99% |
A0A422NT07 | Trypanosoma rangeli | 33% | 100% |
A4IAE5 | Leishmania infantum | 78% | 99% |
C9ZLU8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 28% | 88% |
E9B5G9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 80% | 99% |
Q4Q2G6 | Leishmania major | 78% | 100% |
V5DMU7 | Trypanosoma cruzi | 31% | 100% |